申请人:Astra Pharmaceuticals, Ltd.
公开号:US06063789A1
公开(公告)日:2000-05-16
Compounds of formula I ##STR1## wherein R, R.sup.1, R.sup.2, and R.sup.3 and A are as defined herein, together with pharmaceutically acceptable salts, enantiomers or tautomers are useful as pharmaceuticals, particularly in the treatment of inflammatory disease.
式I的化合物##STR1##其中R、R.sup.1、R.sup.2和R.sup.3以及A如本文所定义,连同药学上可接受的盐、对映体或互变体,在药物中具有用途,特别是在治疗炎症性疾病方面。